Symbiotic anti-oxidant, anti-glycation, and anti-inflammatory qualities of a combination of thiamine and niacin protected type-2 diabetic male rats against both macro and micro-vascular complications

Document Type : Original Article

Authors

1 Department of Clinical Biochemistry, Faculty of Medical Sciences, Ardabil University of Medical Sciences, Ardabil, Iran

2 Medical Student of Ardabil University of Medical Sciences, Ardabil, Iran

10.22038/ijbms.2024.77553.16771

Abstract

Objective(s): Increased nuclear factor (NF-kβ) and carbonyl stress due to decreased glyoxalase-1 activity (Glo-I) contribute significantly to insulin resistance and vascular complications. Therefore, we aimed to study the impact of the combination of thiamine and niacin on hepatic NF-kβ signaling, metabolic profile, and Glo-I activity in male rats with type-2 diabetes (T2DM).
Materials and Methods: Forty male rats were divided equally into five groups: control, diabetic, diabetic treated with thiamine (180 mg/l in drinking water), niacin (180 mg/l), and a combination of both. The treated groups received the treatments daily in drinking water for two months. T2DM was induced using a combination of nicotinamide and alloxan. Metabolic profile and renal dysfunction parameters were assessed. Additionally, various glycation, oxidative stress, and inflammatory markers were measured.
Results: The treated group with both vitamins showed the lowest blood sugar and insulin resistance indices, cardiovascular indices, renal dysfunction parameters, hepatic NF-kβ expression, oxidative stress, inflammatory and glycation markers, and the highest anti-oxidant and anti-glycation markers, β cell activity, and insulin sensitivity. Thiamine exhibited more anti-inflammatory activity than niacin in diabetic rats, while niacin demonstrated stronger anti-oxidant activity (P<0.001).  
Conclusion: The combined use of vitamins had a more beneficial impact on macro and microvascular complications in diabetes than each alone, attributed to their higher anti-oxidant, anti-inflammatory, and anti-glycation characteristics. The vitamins also had a more corrective effect on glucose-lipid metabolism, insulin sensitivity, and renal function through a stronger lowering effect on hepatic NF-kβ expression.

Keywords

Main Subjects

References

1. Ling W HY, Huang YM, Fan RR, Sui Y, Zhao HL. Global trend of diabetes mortality attributed to vascular complications, 2000-2016. Cardiovasc Diabetol 2020; 19:182-194.
2. Suryavanshi SV, Kulkarni YA. NF-κβ: A potential target in the management of vascular complications of diabetes. Front Pharmacol 2017; 8:798-810.
3. Aragonès G, Rowan S, G Francisco S, Yang W, Weinberg J, Taylor A, Bejarano E. Glyoxalase system as a therapeutic target against diabetic retinopathy. Antioxidants (Basel) 2020; 9:1062-1074.
4. Inagi R. RAGE and glyoxalase in kidney disease. Glycoconj J  2016; 33:619-626.
5. Nigro C, Leone A, Raciti GA, Longo M, Mirra P, Formisano P, Beguinot F, Miele C. Methylglyoxal-glyoxalase 1 balance: The root of vascular damage. Int J Mol Sci 2017; 18:188-202.
6. Abdullah KM, Abdul QF, Ahmad I, Naseem I. Inhibitory effect of vitamin B3 against glycation and reactive oxygen species production in HSA: An in vitro approach. Arch Biochem Biophys 2017; 627: 21-29.
7. Maguire D TD, Shiels PG, McMillan D. The role of thiamine dependent enzymes in obesity and obesity related chronic disease states: A systematic review. Clin Nutr ESPEN 2018; 25:8-17.
8. Nix WA, Zirwes R, Bangert V, Kaiser RP, Schilling M, Hostalek U, Obeid R. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. Diabetes Res Clin Pract 2015; 107:157-165.
9. Mahdavifard S, Nakhjavani M. Thiamine pyrophosphate improved vascular complications of diabetes in rats with type 2 diabetes by reducing glycation, oxidative stress, and inflammation markers. Med J Islam Repub Iran 2020; 34:331-336.
10. Xiang D ZQ, Wang YT. Effectiveness of niacin supplementation for patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2020; 99:21235-45
11. Abdullah KM AM, Iqbal Z, Naseem I. Therapeutic effect of vitamin B3 on hyperglycemia, oxidative stress and DNA damage in alloxan induced diabetic rat model. Biomed Pharmacother 2018;105: 1223-1231.
12. Vattam KK, Raghavendran H, Murali MR, Savatey H, Kamarul T. Coadministration of alloxan and nicotinamide in rats produces biochemical changes in blood and pathological alterations comparable to the changes in type II diabetes mellitus. Hum Exp Toxicol 2016; 35:893-901.
13. Mahdavifard S, Dehghani R, Jeddi F, Najafzadeh N. Thiamine reduced metabolic syndrome symptoms in rats via down-regulation of hepatic nuclear factor-kβ and induction activity of glyoxalase-I. Iran J Basic Med Sci 2022; 24:293-229.
14. Song YS, Hwang YC, Ahn HY, Park CY. Comparison of the usefulness of the updated homeostasis model assessment (HOMA2) with the original HOMA1 in the prediction of type 2 diabetes mellitus in koreans. Diabetes Metab J 2016; 40:318-325.
15. Xu YJ, Wu XQ, Liu W, Lin XH, Chen JW, He RQ. A convenient assay of glycoserum by nitroblue tetrazolium with iodoacetamide. Clin Chim Acta  2002; 325:127-131.
16. Pappalardo M, Pappalardo L, Brooks P. Rapid and reliable HPLC method for the simultaneous determination of dihydroxyacetone, methylglyoxal and 5-hydroxymethylfurfural in leptospermum honeys. PLoS One 2016; 11: e0167006.
17. Taylor E, Armstrong KR, Perrett D, Hattersley AT, Winyard PG. Optimisation of an advanced oxidation protein products assay: its application to studies of oxidative stress in diabetes mellitus. Oxid Med Cell Longev 2015; 2015:496271-496281.
18. Begic A, Djuric A, Gobeljic B, Stevanovic I, Lukic V, Stanojevic, I, et al. The simple isocratic HPLC—UV method for the simultaneous determination of reduced and oxidized glutathione in animal tissue. Acta Chromatographica 2017; 29:67-84.
19. Piuri G, Basello K, Rossi G, Soldavini CM, Duiella S, Privitera G, et al. Methylglyoxal, glycated albumin, paf, and tnf-α: possible inflammatory and metabolic biomarkers for management of gestational diabetes. Nutrients 2020; 12:12-27.
20. Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: Causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13:423-444
21. Kroon T BT, Olsén A, Gabrielsson J, Oakes ND. Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]. J Lipid Res 2017; 58:31-41.
22. Abdullah KM, Arefeen A, Anas Sh, Alhumaydhi FA, Naseem I. Insight into the in vitro antiglycation and in vivo antidiabetic effects of thiamine: Implications of vitamin B1 in controlling diabetes. ACS Omega 2021; 6:12605−12614.
23. Xiang S, Li Y, Zhang J, Pan W, Lu Y, Liu SL. Increased dietary niacin intake improves muscle strength, quality, and glucose homeostasis in adults over 40 years of age. J Nutr Health Aging 2023; 27:709-718.
24. Turista DD, Ansori AN, Antonius Y, Posa GA, Rizky WC, Dings TG, et al. In vivo Antidiabetic properties of Etlingera elatior Leaf Extract in Alloxan-Induced Diabetic Rats. Research J Pharm and Tech 2022; 15:1-9.
25. Vekic J, Vujcic S, Bufan B, Bojanin D, Al-Hashmi K, Al-Rasadi K, Stoian AP, Zeljkovic A, Rizzo M., Stoian AP, Zeljkovic A, Rizzo M. The Role of Advanced Glycation End Products on Dyslipidemia. Metabolites 2023; 3:77-91.
26. Gugliucci A MT. Paraoxonase-1 and HDL maturation. Clin Chim Acta  2015; 439:5-13.
27. Eshak ES, Arafa AE. Thiamine deficiency and cardiovascular disorders. Nutr Metab Cardiovasc Dis 2018; 10:965-972.
28. Piuri G, Basello K, Rossi G, Soldavini CM, Duiella S, Privitera G, et al. Methylglyoxal, glycated albumin, PAF, and TNF-α: Possible inflammatory and metabolic biomarkers for management of gestational diabetes. Nutrients 2020; 12:497-509.
29. Kim C, Park K. Dietary niacin intake and risk of dyslipidemia: A pooled analysis of three prospective cohort studies. Clin Nutr 2022; 41:2749-2758.
30. Khatana C, Saini NK, Chakrabarti S, Saini V, Sharma A, Saini RV, Saini AK. Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev 2020; 2020: 5245308-22.
31. Aggarwal G, May-Zhang LS, Yermalitsky V, Dikalov S, Voynov MA, Amarnath V, et al. Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity. J Biol Chem 2021; 297:101019.
32. Yan X, Wang S. The efficacy of niacin supplementation in type 2 diabetes patients: Study protocol of a randomized controlled trial. Medicine (Baltimore) 2021; 100:22272-22276.
33. Yadav R, Liu Y, Kwok S, Hama S, France M, Eatough R, Pemberton P, Schofield J, Siahmansur TJ, Malik R, Ammori BA. Effect of extended-release niacin on high-density lipoprotein (HDL) functionality, lipoprotein metabolism, and mediators of vascular inflammation in statin-treated patients. J Am Heart Assoc 2015; 4:1508-20.
34. Inagi R. RAGE and glyoxalase in kidney disease. Glycoconj J 2016; 33:619-626.
35. Rabbani N TP. Glyoxalase 1 modulation in obesity and diabetes. Antioxid Redox Signal  2019; 20:354-374.
36. Rovira-Llopis S, Rocha M, Falcon R, de Pablo C, Alvarez A, Jover A, Hernandez-Mijares A, Victor VM. Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes? Antioxid Redox Signal 2013; 19:1452-1458.
37. Winarni D HF, Syadzha MF, Susilo RJK, Hayaza S, Ansori ANM, Alamsjah MA, Amin MNG, Wulandari PAC, Pudjiastuti P, Awang K. Topical administration effect of sargassum duplicatum and garcinia mangostana extracts combination on open wound healing process in diabetic mice. Scientifica (Cairo) 2022; 2022:9700794-101.
38. Sharma K. Myeloperoxidase activity and oxidized amino acids as biomarkers in chronic kidney disease and coronary artery disease. Am J Nephrol 2017; 46:71-72.
39. Husen SA AM, Nur A, Hayaza S, Susilo K, Joko R, et al. Renal protective effects of gamma-mangostin in streptozotocin-induced diabetic mice. Indian J Forensic Med Toxicol 2020; 14:1251-1256.
40. Khan MU, Mubeen M, Chohan HK, Jawed S, Jamal A, Qamar JA, et al. Correlation of fasting blood sugar and glycated hemoglobin (HbA1c) with thiamine levels in diabetic patients. Cureus 2023; 15: 46178-46187.
Iranian Journal of Basic Medical Sciences
Volume 28, Issue 1
January 2025
Pages 98-104

Files

Share

How to cite

Statistics